Chimeric lyssavirus glycoproteins with increased immunological potential

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 225-233

  Jallet, Corinne ^a   Jacob, Yves ^a   Bahloul, Chokri ^a   Drings, Astrid ^a   Desmezieres, Emmanuel ^a   Tordo, Noël ^a   Perrin, Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; FEMALE; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RABIES VIRUS;

EID: 0032889310     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.225-233.1999     Document Type: Article

References (17)

1. Amengal, B., J. Whitby, S. Cobo, and H. Bourhy. 1997. Evolution of European bat lyssaviruses. J. Gen. Virol. 78:2319-2328.
2. Bachmann, M., and R. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235-270.
3. Badrane, H., C. Bahloul, P. Perrin, and N. Tordo. Genetic diversity of lyssaviruses: implications in vaccinology, pathogenesis and phylogeny. Submitted for publication.
4. Bahloul, C., Y. Jacob, N. Tordo, and P. Perrin. 1998. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16:417-425.
5. Benmansour, A., H. Leblois, P. Coulon, C. Tuffereau, Y. Gaudin, A. Flamand, and F. Lafay. 1991. Antigenicity of rabies virus glycoprotein. J. Virol. 65:4198-4203.
6. Bourhy, H., B. Kissi, M. Lafon, D. Sacramento, and N. Tordo. 1992. Antigenic and molecular characterization of bat rabies virus in Europe. J. Clin. Microbiol. 30:2419-2426.
7. Bourhy, H., B. Kissi, and N. Tordo. 1993. Molecular diversity of the Lyssavirus genus. Virology 194:70-81.
8. Coulon, P., J.-P. Temaux, A. Flamand, and C. Tuffereau. 1998. An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J. Virol. 72:273-278.
9. Delagneau, J. F., P. Perrin, and P. Atanasiu. 1981. Structure of the rabies virus: spatial relationships of the proteins G, M1, M2 and N. Ann. Inst. Pasteur Virol. 132E:473-493.
10. Dietzschold, B., M. Gore, D. Marchadier, H.-S. Niu, H. Bunschoten, L. Otvos, Jr., W. H. Wunner, H. C. J. ErtI, A. D. M. E. Osterhaus, and H. Koprowski. 1990. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 64:3804-3809.
11. Fekadu, M., J. Shaddock, D. Sanderlin, and J. Smith. 1988. Efficacy of rabies vaccines against virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related virus. Vaccine 6:533-539.
12. Gaudin, Y. 1997. Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones. J. Virol. 71:3742-3750.
13. Gaudin, Y., R. Ruigrok, C. Tuffereau, M. Knossow, and A. Flamand. 1992. Rabies glycoprotein is a trimer. Virology 187:627-632.
14. Gaudin, Y., C. Tuffereau, P. Durrer, A. Flamand, and R. W. H. Ruigrok. 1995. Biological function of the low-PH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation. J. Virol. 69:5528-5534.
15. Gaudin, Y., C. Tuffereau, D. Segrctain, M. Knossow, and A. Flamand. 1991. Reversible conformational changes and fusion activity of rabies virus glycoprotein. J. Virol. 65:4853-4859.
16. Hooper, P., et al. 1997. A new lyssavirus - the first endemic rabies related virus recognized in Australia. Bull. Inst. Pasteur 95:209-218.
17. Joffret, M.-L., C. Zanetti, S. Morgeaux, C. Leclerc, P. Sureau, and P. Perrin. 1991. Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production. Biologicals 19:113-123.